MedTrace Logo

Human Papillomavirus in Cervical Cancer and Pre-cancer in Switzerland: The CIN3+Plus Study

NCT02323997 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 767

Last updated 2019-07-16

No results posted yet for this study

Summary

This study will investigate the types of HPV in samples from women with cervical pre-cancer and cancer and gather information to help investigate the impact of HPV vaccination in Switzerland.

Conditions

Sponsors & Collaborators

  • Federal Office of Public Health, Switzerland

    collaborator OTHER_GOV

  • University of Bern

    lead OTHER

Principal Investigators

  • Nicola Low · University of Bern, Institute of Social and Preventive Medicine

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2015-12-31
Completion
2016-05-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02323997 on ClinicalTrials.gov